Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)

Type 2 diabetes (T2D) imposes a substantial disease burden, predominantly from cardiovascular disease (CVD), which accounts for >50% of deaths in this population and leads to a 12-year reduction in the life expectancy of a 60-year-old male patient with T2D and CVD compared with the general popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Schernthaner, Guntram, Khunti, Kamlesh, Lotan, Chaim, Burnier, Michel, Drexel, Heinz, Prázný, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733371/
https://www.ncbi.nlm.nih.gov/pubmed/29276388
http://dx.doi.org/10.2147/TCRM.S144362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733371/
https://www.ncbi.nlm.nih.gov/pubmed/29276388
http://dx.doi.org/10.2147/TCRM.S144362

Ejemplares similares